[go: up one dir, main page]

PT1337236E - Suplemento a ser administrado entericamente para alimentacao parenterica ou paraalimentacao parcial enterica/ oral de doentes em estado critico, doentes cronicos e de pessoas mal nutridas - Google Patents

Suplemento a ser administrado entericamente para alimentacao parenterica ou paraalimentacao parcial enterica/ oral de doentes em estado critico, doentes cronicos e de pessoas mal nutridas

Info

Publication number
PT1337236E
PT1337236E PT01994656T PT01994656T PT1337236E PT 1337236 E PT1337236 E PT 1337236E PT 01994656 T PT01994656 T PT 01994656T PT 01994656 T PT01994656 T PT 01994656T PT 1337236 E PT1337236 E PT 1337236E
Authority
PT
Portugal
Prior art keywords
supplement
parenteric
nutriental
enterical
chronic
Prior art date
Application number
PT01994656T
Other languages
English (en)
Inventor
Barbara Kessler
Angelika Riedel
Ulrich Suchner
Original Assignee
Fresenius Kabi De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi De Gmbh filed Critical Fresenius Kabi De Gmbh
Publication of PT1337236E publication Critical patent/PT1337236E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT01994656T 2000-11-17 2001-11-14 Suplemento a ser administrado entericamente para alimentacao parenterica ou paraalimentacao parcial enterica/ oral de doentes em estado critico, doentes cronicos e de pessoas mal nutridas PT1337236E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10057290A DE10057290B4 (de) 2000-11-17 2000-11-17 Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten

Publications (1)

Publication Number Publication Date
PT1337236E true PT1337236E (pt) 2004-11-30

Family

ID=7663817

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01994656T PT1337236E (pt) 2000-11-17 2001-11-14 Suplemento a ser administrado entericamente para alimentacao parenterica ou paraalimentacao parcial enterica/ oral de doentes em estado critico, doentes cronicos e de pessoas mal nutridas

Country Status (28)

Country Link
US (1) US7947303B2 (pt)
EP (1) EP1337236B1 (pt)
JP (1) JP2004513912A (pt)
KR (2) KR20080069280A (pt)
CN (1) CN1477950A (pt)
AT (1) ATE272390T1 (pt)
AU (2) AU2002224848B2 (pt)
BR (1) BRPI0115451B1 (pt)
CA (1) CA2429270C (pt)
CZ (1) CZ300129B6 (pt)
DE (2) DE10057290B4 (pt)
DK (1) DK1337236T3 (pt)
EE (1) EE05209B1 (pt)
ES (1) ES2223015T3 (pt)
HR (1) HRP20030395B1 (pt)
HU (1) HU228351B1 (pt)
IL (2) IL155840A0 (pt)
IS (1) IS2377B (pt)
MX (1) MXPA03004348A (pt)
NO (1) NO333003B1 (pt)
NZ (1) NZ525812A (pt)
PL (1) PL202031B1 (pt)
PT (1) PT1337236E (pt)
RU (1) RU2295952C2 (pt)
SI (1) SI1337236T1 (pt)
SK (1) SK286199B6 (pt)
WO (1) WO2002039978A1 (pt)
ZA (1) ZA200303722B (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10254584A1 (de) * 2002-11-22 2004-06-09 HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker
US20070026090A1 (en) * 2003-09-05 2007-02-01 Oren Tirosh Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium
NZ546009A (en) * 2003-09-19 2010-02-26 Nutricia Nv Method and composition for preventing multiple organ dysfunction syndrome
DE10349585A1 (de) 2003-10-24 2005-06-16 Biosyn Arzneimittel Gmbh Spurenelementzusammensetzung für die Ernährung
DE202004015931U1 (de) * 2004-10-13 2005-01-05 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Omega-3-Fettsäuren und Omega-6-Fettsäuren enthaltende Zusammensetzung
US20050148669A1 (en) * 2004-10-21 2005-07-07 Daniel Amato Amino acid esters as nutrient supplements and methods of use
US11077165B2 (en) * 2004-11-09 2021-08-03 Hills Pet Nutrition, Inc. Use of antioxidants for gene modulation
EP1841445A4 (en) * 2004-12-21 2010-06-02 Critical Care Connections Inc THERAPEUTIC NUTRIENT COMPOSITIONS OR COMBINATIONS AND METHODS OF USE
ES2484798T5 (es) * 2005-04-27 2022-08-16 Nutricia Nv Alimentación con lípidos y sacáridos no digeribles
EP1719543A1 (en) * 2005-05-04 2006-11-08 Asan Labs., Ltd. Use of histone deacetylase inhibitors for the treatment of gastrointestinal distress
US20090104705A1 (en) * 2005-05-23 2009-04-23 Jan Frederik Stevens Ascorbic acid conjugates
MX2008002701A (es) * 2005-08-26 2008-03-18 Nestec Sa Nutricion para pacientes obesos.
DE102005046237A1 (de) * 2005-09-28 2007-04-05 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Buttersäureester von Kohlenhydraten und Kohlenhydratpolyolen
US20090312427A1 (en) * 2005-11-15 2009-12-17 Entress Ab Medicament for Use in Connection With Cartilage Impairment
US20090011077A1 (en) * 2006-01-09 2009-01-08 Nestec S.A. Treatment of Stressed Patients
US20100215631A1 (en) * 2006-06-14 2010-08-26 Anita Hartog Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof
JP5787480B2 (ja) * 2006-10-19 2015-09-30 ネステク ソシエテ アノニム 維持のための長期経腸栄養供給
KR100774816B1 (ko) * 2006-11-21 2007-11-07 동부일렉트로닉스 주식회사 반도체 소자의 ｍｉｍ 커패시터 제조 방법 및 구조
PT2190304E (pt) * 2007-09-17 2012-03-20 Nutricia Nv Formulação nutricional com alto teor energético
CN101896176A (zh) * 2007-10-14 2010-11-24 佛罗里达大学研究基金公司 改善胃肠道功能的制剂
RU2354380C1 (ru) * 2007-11-16 2009-05-10 Государственное образовательное учреждение высшего профессионального образования "Омская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Росздрава" Способ медикаментозной коррекции вазомоторной функции эндотелия у детей с сахарным диабетом 1 типа, не имеющих микроангиопатий
RU2394583C1 (ru) * 2008-12-01 2010-07-20 Марк Абович Малков Средство для профилактики обменных нарушений
IT1396935B1 (it) 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
CN103025178B (zh) * 2010-04-26 2015-02-11 雀巢产品技术援助有限公司 用于从胃肠外营养转换至肠内营养的营养组合物和方法
CN103458887A (zh) * 2011-03-31 2013-12-18 雀巢产品技术援助有限公司 用于增加精氨酸水平的营养组合物及其使用方法
KR102100091B1 (ko) 2011-04-13 2020-04-14 아지노모토 가부시키가이샤 영양 조성물
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
US9849144B2 (en) 2013-09-16 2017-12-26 Healios Oncology Nutrition, LLC Glutamine and trehalose compositions
KR101572606B1 (ko) * 2014-11-24 2015-11-27 강원대학교산학협력단 Sfrp5 유래의 펩타이드 및 이를 포함하는 피부 미백용 화장료 조성물
WO2016199798A1 (ja) 2015-06-10 2016-12-15 味の素株式会社 運動誘発性の消化管障害の改善剤
ES2638195B1 (es) * 2016-04-18 2018-08-02 Bioiberica, S.A. Composiciones para la piel
US11623043B2 (en) 2017-05-09 2023-04-11 Baxter International Inc. Parenteral nutrition diagnostic system, apparatus, and method
CN108208177A (zh) * 2017-11-28 2018-06-29 上海交通大学医学院附属新华医院 含丁酸类化合物的组合物及其应用
PL423673A1 (pl) * 2017-12-01 2019-06-03 Lewandowska Agata Kompozycja do podawania doustnego, zastosowanie kompozycji w zapobieganiu i leczeniu mucositis oraz sposób leczenia mucositis
KR20220139955A (ko) * 2020-02-12 2022-10-17 디에스엠 아이피 어셋츠 비.브이. 장으로의 산화방지제의 직접 전달
WO2021191469A1 (en) * 2020-03-27 2021-09-30 Basf Se Composition for the treatment of gastro-intestinal dysfunction and/or associated morbidities thereto
US11666548B2 (en) * 2020-06-05 2023-06-06 Baxter International Inc. Parenteral nutrition formulation
US20220160669A1 (en) 2020-11-24 2022-05-26 Baxter International Inc. Parenteral nutrition formulation
DE202021102589U1 (de) 2020-12-15 2021-05-28 Marco Lautenschläger Verzehrfertiges, abgefülltes Getränk auf Basis eines natürlichen Mineralwassers
WO2023205635A1 (en) * 2022-04-19 2023-10-26 Vanderbilt University Compositions and methods of treatment for congenital diarrheal disorder
WO2023215458A1 (en) * 2022-05-06 2023-11-09 Ageless Sciences, Inc. Compositions and methods for slowing down aging and extending lifespan
CN116920075B (zh) * 2023-09-15 2024-01-02 潍坊市人民医院(潍坊市公共卫生临床中心) 一种肠内营养液及其制备方法
CN120419671B (zh) * 2025-06-26 2025-10-10 成都桥然生物科技有限公司 一种儿童促生长双组分复合物配方及其制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3698912A (en) * 1969-07-01 1972-10-17 Morton Norwich Products Inc Process for making nutrient composition
DE3135849A1 (de) * 1981-09-10 1983-03-17 Dr. Schumacher GmbH & Co KG, 4600 Dortmund Beschichtungsstoff fuer korrosionsschutzzwecke
US4446389A (en) * 1982-03-15 1984-05-01 Ampex Corporation Quadrature tach decoder circuit
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
IL94549A (en) * 1989-06-02 1996-08-04 Brigham & Womens Hospital A pharmaceutical preparation containing glutamine
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
JP2524551B2 (ja) * 1992-02-28 1996-08-14 雪印乳業株式会社 グルタミン含量の高いペプチド組成物、その製造方法及び経腸栄養剤
WO1994014458A1 (en) 1992-12-23 1994-07-07 Abbott Laboratories Medical foods for the nutritional support of infant/toddler metabolic diseases
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
JP4059532B2 (ja) * 1994-08-15 2008-03-12 森永乳業株式会社 腸内細菌の体内移行を阻止するペプチド混合物と、このペプチド混合物を含有する組成物
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
JP4011638B2 (ja) * 1994-12-27 2007-11-21 イーエヌ大塚製薬株式会社 経口経腸栄養組成物
US5569680A (en) * 1995-02-13 1996-10-29 Trustees Of The Univ. Of Penna Method of treating inflammatory bowel disease with tributyrin
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
JPH09323979A (ja) * 1996-06-04 1997-12-16 Meiji Milk Prod Co Ltd 核酸を用いた免疫調節組成物
GB9701674D0 (en) * 1997-01-28 1997-03-19 Novartis Nutrition Ag Use of organic compounds
US6124486A (en) * 1997-01-31 2000-09-26 Eastman Chemical Company Process for making low calorie triglycerides having long and short fatty acid chains
WO1998041216A1 (en) * 1997-03-17 1998-09-24 Tam Yun K Composition for prevention of hepatic steatosis
GB9709082D0 (en) * 1997-05-06 1997-06-25 Ciba Geigy Ag Organic compositions
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
AU2186699A (en) * 1998-02-09 1999-08-23 Meiji Milk Products Co., Ltd. Preventives and remedies for intestinal mucosal disorder
US6369252B1 (en) * 1998-02-26 2002-04-09 The University Of Georgia Research Foundation, Inc. Structured lipids
MXPA01002447A (es) * 1998-09-11 2002-11-29 Cultor Food Science Inc Composicion de grasa plastica baja en calorias.
JP2000119180A (ja) * 1998-10-06 2000-04-25 Nisshin Flour Milling Co Ltd 経腸栄養剤
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives

Also Published As

Publication number Publication date
HUP0301386A3 (en) 2008-04-28
NZ525812A (en) 2004-03-26
NO333003B1 (no) 2013-02-11
JP2004513912A (ja) 2004-05-13
KR100861889B1 (ko) 2008-10-09
PL202031B1 (pl) 2009-05-29
AU2002224848B2 (en) 2006-06-15
BRPI0115451B1 (pt) 2016-07-19
SI1337236T1 (en) 2004-12-31
WO2002039978A1 (de) 2002-05-23
CZ300129B6 (cs) 2009-02-18
CA2429270A1 (en) 2002-05-23
IL155840A0 (en) 2003-12-23
DE10057290B4 (de) 2004-01-08
KR20030069172A (ko) 2003-08-25
IL155840A (en) 2008-11-03
HU228351B1 (hu) 2013-03-28
BR0115451A (pt) 2004-01-06
EE200300198A (et) 2003-08-15
US20040097404A1 (en) 2004-05-20
HRP20030395B1 (hr) 2011-10-31
ZA200303722B (en) 2004-04-16
HUP0301386A2 (hu) 2003-09-29
DK1337236T3 (da) 2004-12-13
MXPA03004348A (es) 2003-08-19
WO2002039978A8 (de) 2002-07-18
HRP20030395A2 (en) 2005-04-30
KR20080069280A (ko) 2008-07-25
IS6815A (is) 2003-05-14
NO20032160D0 (no) 2003-05-13
NO20032160L (no) 2003-07-14
PL361634A1 (en) 2004-10-04
EE05209B1 (et) 2009-10-15
IS2377B (is) 2008-07-15
ATE272390T1 (de) 2004-08-15
DE50103152D1 (de) 2004-09-09
DE10057290A1 (de) 2002-06-06
RU2295952C2 (ru) 2007-03-27
ES2223015T3 (es) 2005-02-16
US7947303B2 (en) 2011-05-24
CN1477950A (zh) 2004-02-25
CA2429270C (en) 2009-08-18
CZ20031337A3 (cs) 2003-09-17
SK5612003A3 (en) 2003-10-07
EP1337236B1 (de) 2004-08-04
AU2484802A (en) 2002-05-27
SK286199B6 (sk) 2008-05-06
EP1337236A1 (de) 2003-08-27

Similar Documents

Publication Publication Date Title
PT1337236E (pt) Suplemento a ser administrado entericamente para alimentacao parenterica ou paraalimentacao parcial enterica/ oral de doentes em estado critico, doentes cronicos e de pessoas mal nutridas
KR920000324A (ko) 필수 지방산 처리법
BR9909672A (pt) uso de um composto medicinal ativo no preparo de um medicamento para o tratamento de hipertensão
BR0106681A (pt) Fórmula pediátrica e métodos para prover nutrição a pacientes pediátricos e para melhorar tolerância em pacientes pediátricos
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
BR0211814A (pt) Formulação contendo (liso-)fosfatidilserina para a prevenção e tratamento de estados de tensão em animais de sangue quente
BR0115985A (pt) Preparação farmacêutica em forma de uma pasta compreendendo um ingrediente ativo ácido-lábil
BR9709838A (pt) Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase
MX9205722A (es) Composicion alimenticia enteral contra el cancer
ES2175663T3 (es) Composiciones farmaceuticas solidas que contienen miltefosina para administracion oral en el tratamiento de la leshmaniasis.
IT1315252B1 (it) Compresse gastroresistenti ad uso alimentare o dietetico ottenutemediante grassi miscelati alla massa
CN110730659A (zh) 用于提高l-dopa治疗功效的组合物
IT1295408B1 (it) Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
ES2250726T3 (es) Utilizacion de extractos de ginkgo biloba para preparar un medicamento destinado a tratar la sarcopenia.
ATE92756T1 (de) Mittel zur behandlung von keratose.
ES2038847T3 (es) Proceso para la preparacion de una composicion farmacutica conteniendo zidovudine e inosiplex para el tratamiento del sida y sindromes afines.
Vanderzant et al. Treatment of primary reading epilepsy with valproic acid
BRPI0411436A (pt) composição, suplemento dietético, composição farmacêutica, e, métodos de tratamento para cáncer de fìgado, para danos ao fìgado causados por quimioembolização, e de um distúrbio do sistema hepatobiliar, e para cirrose e hepatite de fìgado
RU2843163C1 (ru) Способ профилактики НПВС-гастропатии
PT1208078E (pt) Sais nao higroscopicos de substancias activas com actividades terapeuticas e/ou nutricionais e composicoes passiveis de serem administradas oralmente contendo os mesmos
Al–Saffar The therapeutic effect of viscous solution of curcumine in the treatment of recurrent aphthous stomatitis (RAS)
KR910018030A (ko) 뇌의 노화 및 중추신장계 기능 결손 상태의 예방 및 치료를 위한 더마탄 설페이트의 용도
Ursini et al. Nutritional supplementation for osteoarthritis
Parulkar et al. Annular scaly plaques in a girl
Munk Protease paunch?